New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine…

Read more

Strategic Media Partner

Form

Don't Miss a Breakthrough in Cancer Research.   Join NFCR today to be a part of the cure.